OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-10861018
  • Global Heathcare EDI Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: October 2018 | Report Code: HHE-10861018

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The global healthcare EDI market is growing at the CAGR of 14.6% and will contribute $2900 million till 2022. Electronic Data Interchange (EDI) is an advanced electronic communication technology that offers exchange data standards, for interchange of data into any kind of electronic technology. The EDI or electronic data exchange permits interchange of important data between two or more companies, situated in different countries, by application of assured standards of EDI. EDI can be well-defined as, exchange of data, by using encoded message terms and standards, from one computer device to another, without any human or mechanical interference. In 1996, Electronic data exchange was launched by National Institute of Standards and Technology. Healthcare Electronic Data Exchange (EDI) is the systematic application of EDI in the field of healthcare. EDI has played an appreciated role in the healthcare sector. It is very difficult to manage the data in healthcare field, such as, medication data, emergency services records, patient history records, and others. Though, EDI helped to manage this massive data in an easy accessible, efficient and systematic manner. EDI is applied in almost all sub-divisions of healthcare sector, since it saves a lot of money and time, and ultimately drives the healthcare industry. As of now, major usage of EDI in the healthcare industry include dental and medical patient database management, clinical trials and regulatory data management, insurance and reimbursement sector and others.
 
The market of healthcare EDI is boosted by many influencing factors, such as, increase in prevalence of chronic diseases and growing awareness, rapidly growing technology and its applications in the healthcare industry. This is supported by rapidly rising clinical trials and R&D, increasing base of end-users such as private payers and hospitals, and strong focus on reimbursement and insurance claims. Rapidly enhancing technological applications is considered as the most important catalysts supporting the growth of the global healthcare EDI market. Due to this, a large amount of money and time has been saved in healthcare data management which finally contributes in the growth of the industry.
 
The technology also has certain restraints to overcome, such as reimbursement issues, management of data, expensive EDI software, and lack of technical expertise and sufficient knowledge base. Data safety and integrity is also a key concern. The technology has several opportunities as well. The introduction and implementation of Electronic Health Records (EHR), the increasing investments in venture capital funds, and the implementation of trends in the medical-IT field presents a significant opportunity for this sector.
 
Limited technological access in under developed and rural region of the world, threat of loss of system database due to technical issues are some of the limitations, anticipated to hinder the growth of global healthcare EDI market. Also, financial limitations also act as a barrier in the penetration of EDI.
 
The global healthcare EDI market is majorly segmented into end user, product and regional outlook. In end user segment, market is divided into healthcare providers and medical equipment and accessories suppliers/ pharmacies. The healthcare providers are subdivided into healthcare payers, government/ public payers and private payers. In product segment, market is divided into component, type of transaction, mode of delivery EDI van and mobile EDI. Component segment is subdivided into software and services. Type of transaction segment is subdivided into claim status, eligibility verification, payment remittance, referral certification, enrollment/ disenrollment transactions and premium payment. Mode of delivery segment is subdivided into web based EDI/ EDI cloud, EDI via AS2 and Point to point EDI.
 
Globally, the healthcare EDI market is divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global healthcare EDI market. The U.S. has been a leader in the development of IT infrastructure for the healthcare industry and is a deep-rooted market for healthcare IT solutions. But, there lies more growth opportunity for the healthcare EDI market in the North American countries considering the presence of large hospitals in the U.S., demanding advanced IT solutions to streamline the processes and availability of government funding for healthcare providers towards the development of health services. Europe region is also showing positive growth rate due to government funding towards healthcare sector. Asia Pacific region is the fastest growing market and will grow further in the forecast period. Government initiatives for the support of healthcare IT, large population, and growing burden of diseases are some of the factor responsible for the growth of Asia Pacific region. Rest of the world is showing lucrative growth in the next five years, reason being penetration of healthcare sector and its services in this region.
 
Some of the key market players are Linoma software, Interactive Intelligence, Emdeon Inc., Zirmed Inc., Allscripts Healthcare solutions Inc., Siemens Healthcare, Plexis healthcare systems Inc., Passport health communication Inc., Omnivex Corporation, Mckesson Corporation, etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL HEALTHCARE EDI MARKET : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE   
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. THE HEALTHCARE INSURANCE PORTABILITY AND ACCOUNTABILITY ACT, 1886, TO PROPEL THE ADOPTION OF EDI IN HEALTHCARE
3.1.2. PATIENT PROTECTION AND AFFORDABILITY CARE ACT
3.1.3. INITIATIVES BY DIFFERENT GOVERNMENTS FOR ENCOURAGEMENT OF HEALTHCARE IT
3.2. MARKET RESTRAINTS
3.2.1. DATA SECURITY, A MAJOR CONCERN FOR PATIENTS AND EDI USERS
3.2.2. HIGH COST OF EDI SOFTWARE
3.2.3. EDI MANAGEMENT, A MAJOR CHALLENGE INHIBITING THE ADOPTION OF EDI
3.2.4. RESTRICTED INVESTMENT IN HEALTHCARE IT
3.2.5. LIMITED REIMBURSEMENTS TO HINDER THE GROWTH IN THE BRIC NATIONS
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASE IN THE OUTSOURCING OF EDI SERVICES
3.3.2. CONVERSION FROM ICD-8 TO ICD-10
3.4.   MARKET CHALLENGES
3.4.1. DATA SECURITY FOR PATIENTS AND EDI USERS
3.4.2. EDI MANAGEMENT
 
4. GLOBAL HEALTHCARE EDI MARKET BY PRODUCT
4.1. MARKET DEFINITION AND SCOPE
4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4. OPPORTUNITY MATRIX
4.5. MARKET SEGMENTATION
4.5.1. GLOBAL COMPONENT MARKET
4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.1.3. KEY CONCLUSIONS
4.5.1.4. SUB SEGMENT
4.5.1.4.1. SOFTWARE
4.5.1.4.2.    SERVICES
4.5.2. GLOBAL TYPE OF TRANSACTION MARKET
4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.2.3. KEY CONCLUSIONS
4.5.2.4. SUB SEGMENT
4.5.2.4.1.      CLAIM STATUS
4.5.2.4.2.      ELIGIBILITY VERIFICATION
4.5.2.4.3.      PAYMENT REMITTANCE
4.5.2.4.4.      REFERRAL CERTIFICATION AUTHORIZATION
4.5.2.4.5.      ENROLLMENT/DISENROLLMENT TRANSACTIONS
4.5.2.4.6.      PREMIUM PAYMENTS
4.5.3. GLOBAL MODE OF DELIVERY MARKET
4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.3.3. KEY CONCLUSIONS
4.5.3.4. SUB SEGMENT
4.5.3.4.1. WEB-BASED EDI/EDI CLOUD
4.5.3.4.2.      POINT-TO-POINT EDI
4.5.3.4.3.      EDI VAN
4.5.3.4.4.      MOBILE EDI
4.5.3.4.5. OTHERS
 
5. GLOBAL HEALTHCARE EDI MARKET BY END USER
5.1. MARKET DEFINITION AND SCOPE
5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
5.4. OPPORTUNITY MATRIX
5.5. MARKET SEGMENTATION
5.5.1. GLOBAL HEALTHCARE PROVIDERS MARKET
5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.1.3. KEY CONCLUSIONS
5.5.1.4. SUB SEGMENT
5.5.1.4.1. HEALTHCARE PAYERS
5.5.1.4.2.    GOVERNMENT/PUBLIC PAYERS
5.5.1.4.3.    PRIVATE PAYERS
5.5.1.4.4.    GOVERNMENT/PUBLIC PAYERS
5.5.1.4.5.    PRIVATE PAYERS
5.5.2. GLOBAL MEDICAL EQUIPMENT AND ACCESSORIES MARKET
5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.2.3. KEY CONCLUSIONS
5.5.3. GLOBAL SUPPLIERS/PHARMACIES MARKET
5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.3.3. KEY CONCLUSIONS
 
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIES
6.1.1. LIST OF MERGERS AND ACQUISITION
6.1.2. LIST OF JOINT VENTURES
6.1.3. LIST OF PRODUCT LAUNCHES
6.1.4. LIST OF PARTNERSHIPS
 
7. GEOGRAPHIC ANALYSIS
7.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
7.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
7.3. OPPORTUNITY MATRIX
7.4. GLOBAL HEALTHCARE EDI MARKET BY REGION 2015-2024  
7.4.1. NORTH AMERICA
7.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.1.2. TOP COUNTRY ANALYSIS
7.4.1.2.1. U.S.
7.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.1.2.1.2. KEY CONCLUSIONS
7.4.1.2.2. CANADA
7.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.1.2.2.2. KEY CONCLUSIONS
7.4.2. EUROPE
7.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.2.2. TOP COUNTRY ANALYSIS
7.4.2.2.1. UK
7.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.1.2. KEY CONCLUSIONS
7.4.2.2.2. FRANCE
7.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.2.2. KEY CONCLUSIONS
7.4.2.2.3. GERMANY
7.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.3.2. KEY CONCLUSIONS
7.4.2.2.4. SPAIN
7.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.4.2. KEY CONCLUSIONS
7.4.2.2.5. REST OF EUROPE
7.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.5.2. KEY CONCLUSIONS
7.4.3. ASIA PACIFIC
7.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.3.2. TOP COUNTRY ANALYSIS
7.4.3.2.1. CHINA
7.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.1.2. KEY CONCLUSIONS
7.4.3.2.2. INDIA
7.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.2.2. KEY CONCLUSIONS
7.4.3.2.3. JAPAN
7.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.3.2. KEY CONCLUSIONS
7.4.3.2.4. AUSTRALIA
7.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.4.2. KEY CONCLUSIONS
7.4.3.2.5. REST OF ASIA PACIFIC
7.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.5.2. KEY CONCLUSIONS
7.4.4. ROW
7.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.4.2. TOP COUNTRY ANALYSIS
7.4.4.2.1. LATIN AMERICA
7.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.4.2.1.2. KEY CONCLUSIONS
7.4.4.2.2. MIDDLE EAST & AFRICA
7.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.4.2.2.2. KEY CONCLUSIONS
 
8. COMPANY PROFILES
8.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
8.1.1. OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
 
8.2. CAPARIO INC.(US)
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.2.4. SCOT ANALYSIS
8.2.5. STRATEGIC ANALYSIS
 
8.3. CONCENTRIX CORPORATION(GERMANY)
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.3.4. SCOT ANALYSIS
8.3.5. STRATEGIC ANALYSIS
 
8.4. EMDEON INC.
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
 
8.5. GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY)(UK)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
 
8.6. INTERACTIVE INTELLIGENCE(US)
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.6.4. SCOT ANALYSIS
8.6.5. STRATEGIC ANALYSIS
 
8.7. LINOMA SOFTWARE
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.7.4. SCOT ANALYSIS
8.7.5. STRATEGIC ANALYSIS
 
8.8. MCKESSON CORPORATION(US)
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.8.4. SCOT ANALYSIS
8.8.5. STRATEGIC ANALYSIS
 
8.9. OMNIVEX CORPORATION(CANDA)
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.9.4. SCOT ANALYSIS
8.9.5. STRATEGIC ANALYSIS
 
8.10. OPTUM INC.(US)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
 
8.11. PASSPORT HEALTH COMMUNICATIONS INC.
8.11.1. OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.11.4. SCOT ANALYSIS
8.11.5. STRATEGIC ANALYSIS
 
8.12. PLEXIS HEALTHCARE SYSTEMS, INC.(US)
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. STRATEGIC INITIATIVES
8.12.4. SCOT ANALYSIS
8.12.5. STRATEGIC ANALYSIS
 
8.13. SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG.)(GERMANY)
8.13.1. OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.13.4. SCOT ANALYSIS
8.13.5. STRATEGIC ANALYSIS
 
8.14. SSI GROUP INC.
8.14.1. OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.14.4. SCOT ANALYSIS
8.14.5. STRATEGIC ANALYSIS
 
8.15. ZIRMED INC.
8.15.1. OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.15.4. SCOT ANALYSIS
8.15.5. STRATEGIC ANALYSIS
 
1. LIST OF TABLES
2. GLOBAL HEALTHCARE EDI MARKET BY PRODUCT 2015-2024 ($ MILLION)
3. GLOBAL COMPONENT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
4. GLOBAL HEALTHCARE EDI MARKET BY COMPONENT 2015-2024 ($ MILLION)
5. GLOBAL TYPE OF TRANSACTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL HEALTHCARE EDI MARKET BY TYPE OF TRANSACTION 2015-2024 ($ MILLION)
7. GLOBAL  MODE OF DELIVERY  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
8. GLOBAL HEALTCARE EDI MAREKT BY  MODE OF DELIVERY 2015-2024 ($ MILLION)
9. GLOBAL HEALTHCARE EDI MARKET BY END USER 2015-2024 ($ MILLION)
10. GLOBAL HEALTHCARE PROVIDERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. GLOBAL HEALTHCARE EDI MARKET BY HEALTHCARE PROVIDERS 2015-2024 ($ MILLION)
12. GLOBAL  MEDICAL EQUIPMENT AND ACCESSORIES SUPPLIERS/PHARMACIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
13. NORTH AMERICA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
14. EUROPE HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
15. ASIA PACIFIC HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
16. REST OF THE WORLD HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
17. NORTH AMERICA HEALTHCARE EDI MARKET BY PRODUCT 2015-2024 ($ MILLION)
18. EUROPE HEALTHCARE EDI MARKET BY PRODUCT 2015-2024 ($ MILLION)
19. ASIA PACIFIC HEALTHCARE EDI MARKET BY PRODUCT 2015-2024 ($ MILLION)
20. REST OF THE WORLD FINTECH BLOCKCHAINMARKET BY PRODUCT 2015-2024 ($ MILLION)
21. NORTH AMERICA HEALTHCARE EDI  MARKET BY END USER  2015-2024 ($ MILLION)
22. EUROPE HEALTHCARE EDI MARKET BY END USER 2015-2024 ($ MILLION)
23. ASIA PACIFIC HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
24. REST OF THE WORLD HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
25. UNITED STATES HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
26. UNITED STATES HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
27. CANADA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
28. CANADA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
29. UK HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
30. UK HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
31. FRANCE HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
32. FRANCE HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
33. GERMANY HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
34. GERMANY HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
35. SPAIN HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
36. SPAIN HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
37. ROE HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
38. ROE HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
39. CHINA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
40. CHINA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
41. INDIA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
42. INDIA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
43. JAPAN HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
44. JAPAN HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
45. AUSTRALIA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
46. AUSTRALIA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
47. ROAPAC HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
48. ROAPAC HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
49. LATIN AMERICA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
50. LATIN AMERICA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
51. MENA HEALTHCARE EDI  MARKET BY PRODUCT  2015-2024 ($ MILLION)
52. MENA HEALTHCARE EDI  MARKET BY END USER 2015-2024 ($ MILLION)
 
1. LIST OF FIGURES
2. GLOBAL COMPONENT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
3. GLOBAL HEALTHCARE EDI MARKET BY COMPONENT 2015-2024 ($ MILLION)
4. GLOBAL TYPE OF TRANSACTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL HEALTHCARE EDI MARKET BY TYPE OF TRANSACTION 2015-2024 ($ MILLION)
6. GLOBAL  MODE OF DELIVERY  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL HEALTHCARE EDI MARKET BY END USER 2015-2024 ($ MILLION)
8. GLOBAL HEALTHCARE PROVIDERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
9. GLOBAL HEALTHCARE EDI MARKET BY HEALTHCARE PROVIDERS 2015-2024 ($ MILLION)
10. GLOBAL  MEDICAL EQUIPMENT AND ACCESSORIES SUPPLIERS/PHARMACIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. UNITED STATES (U.S.) HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
12. CANADA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
13. UNITED KINGDOM (UK) HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
14. FRANCE HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
15. GERMANY HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
16. SPAIN HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
17. ROE HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
18. CHINA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
19. INDIA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
20. JAPAN HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
21. AUSTRALIA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
22. ROAPAC HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
23. LATIN AMERICA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION)
24. MENA HEALTHCARE EDI MARKET 2015-2024 ($ MILLION) 
 
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.